Literature DB >> 13472066

PREDNISOLONE in the treatment of pulmonary tuberculosis: a controlled trial; a preliminary report by the Research Committee of the Tuberculosis Society of Scotland.

.   

Abstract

Entities:  

Keywords:  PREDNISOLONE/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1957        PMID： 13472066      PMCID： PMC1962970     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  A review of 138 cases of closure of tuberculous lung cavities under chemotherapy.

Authors:  J D ROSS; D T KAY
Journal:  Thorax       Date:  1956-03       Impact factor: 9.139

2.  The effects of corticotropin (ACTH) and cortisone in fifteen cases of pulmonary tuberculosis.

Authors:  G S BERG; E J DES AUTELS; J FERSHING; S FREEMAN; J R ZVETINA
Journal:  Dis Chest       Date:  1956-11

3.  Cortisone, corticotropin, and antimicrobial therapy in tuberculosis in animals and man; a review.

Authors:  J R JOHNSON; W N DAVEY
Journal:  Am Rev Tuberc       Date:  1954-10

4.  Enhancing effect of cortisone on tuberculosis in the mouse.

Authors:  P D'ARCY HART; R J W REES
Journal:  Lancet       Date:  1950-09-23       Impact factor: 79.321

5.  Cortisone in the treatment of pulmonary tuberculosis.

Authors:  J B COCHRAN
Journal:  Edinb Med J       Date:  1954-07
  5 in total
  2 in total

Review 1.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

2.  Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosis.

Authors:  Lorna Gcanga; Ousman Tamgue; Mumin Ozturk; Shandre Pillay; Raygaana Jacobs; Julius Ebua Chia; Stanley Kimbung Mbandi; Malika Davids; Keertan Dheda; Sebastian Schmeier; Tanvir Alam; Sugata Roy; Harukazu Suzuki; Frank Brombacher; Reto Guler
Journal:  Nucleic Acid Ther       Date:  2022-07-27       Impact factor: 4.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.